HLA antibodies in pediatric heart transplantation

Pediatric Transplantation

Volumn 15, Issue 5, 2011, Pages 458-464

  Ho, Eric K ^a   Vasilescu, Elena R ^a   Vlad, George ^a   Marboe, Charles C ^a   Addonizio, Linda J ^b   Suciu Foca, Nicole ^a  

^a NewYork Presbyterian Hospital   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

anti HLA antibodies; antibody mediated rejection; complement mediated cytotoxicity; pediatric heart transplant; post transplant monitoring of antibodies; solid phase assays

Indexed keywords

HLA ANTIBODY;

ADOLESCENT; ARTICLE; B LYMPHOCYTE; CHILD; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PEDIATRIC SURGERY; PRESCHOOL CHILD; SCHOOL CHILD; SURVIVAL RATE; T LYMPHOCYTE;

ADOLESCENT; ANTIBODIES; B-LYMPHOCYTES; BIOPSY; CHILD; CHILD, PRESCHOOL; COMPLEMENT SYSTEM PROTEINS; ENDOCARDIUM; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOPHENOTYPING; INFANT; INFANT, NEWBORN; MALE; MYOCARDIUM; PEDIATRICS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79960575906     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2010.01435.x     Document Type: Article

References (31)

1. Groetzner J, Reichart B, Roemer U, et al., Cardiac transplantation in pediatric patients: Fifteen-year experience of a single center. Ann Thorac Surg 2005: 79: 53-60. (Pubitemid 40037438)
2. Brancaccio G, Amodeo A, Ricci Z, et al., Mechanical assist device as a bridge to heart transplantation in children less than 10 kilograms. Ann Thorac Surg 2010: 90: 58-62.
3. Gandhi SK, Huddleston CB, Balzer DT, et al., Biventricular assist devices as a bridge to heart transplantation in small children. Circulation 2008: 118: S89-S93.
4. Jacobs JP, Quintessenza JA, Boucek RJ, et al., Pediatric cardiac transplantation in children with high panel reactive antibody. Ann Thorac Surg 2004: 78: 1703-1709. (Pubitemid 39423539)
5. McNeer B, Dickason B, Niles S, et al., Pediatric orthotopic heart transplant requiring perioperative exchange transfusion: A case report. J Extra Corpor Technol 2004: 36: 361-363. (Pubitemid 40082887)
6. Stewart S, Winters GL, Fishbein MC, et al., Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005: 24: 1710-1720. (Pubitemid 41641841)
7. Suciu-Foca N, Reed E, Marboe C, et al., The role of anti-HLA antibodies in heart transplantation. Transplantation 1991: 51: 716-724.
8. Itescu S, Tung TC, Burke EM, et al., An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients. Lancet 1998: 352: 263-270. (Pubitemid 28340143)
9. Itescu S, Tung TC, Burke EM, et al., Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. Circulation 1998: 98: 786-793. (Pubitemid 28391844)
10. John R, Lietz K, Burke E, et al., Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients. Circulation 1999: 100: II229-II235. (Pubitemid 29523540)
11. Cherry R, Nielsen H, Reed E, et al., Vascular (humoral) rejection in human cardiac allograft biopsies: Relation to circulating anti-HLA antibodies. J Heart Lung Transplant 1992: 11: 24-29; discussion 30.
12. Reed EF, Hong B, Ho E, et al., Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease. Transplantation 1996: 61: 566-572. (Pubitemid 26073600)
13. Vasilescu ER, Ho EK, De La Torre L, et al., Anti-HLA antibodies in heart transplantation. Transpl Immunol 2004: 12: 177-183. (Pubitemid 38223978)
14. Vasilescu ER, Ho EK, Colovai AI, et al., Alloantibodies and the outcome of cadaver kidney allografts. Hum Immunol 2006: 67: 597-604. (Pubitemid 44205321)
15. Ho EK, Vlad G, Colovai AI, et al., Alloantibodies in heart transplantation. Hum Immunol 2009: 70: 825-829.
16. Billingham ME, Cary NR, Hammond ME, et al., A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990: 9: 587-593.
17. Reed EF, Demetris AJ, Hammond E, et al., Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 2006: 25: 153-159. (Pubitemid 43156365)
18. Ho EK, Vlad G, Vasilescu ER, et al., Pre- and posttransplantation allosensitization in heart allograft recipients: Major impact of de novo alloantibody production on allograft survival. Hum Immunol. 2010: doi:10.1016/j.humimm.2010.10.013.
19. Michaels PJ, Espejo ML, Kobashigawa J, et al., Humoral rejection in cardiac transplantation: Risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 2003: 22: 58-69. (Pubitemid 36071418)
20. Kfoury AG, Stehlik J, Renlund DG, et al., Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: Defining rejection patterns. J Heart Lung Transplant 2006: 25: 1277-1282. (Pubitemid 44767730)
21. Tambur AR, Pamboukian SV, Costanzo MR, et al., The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome. Transplantation 2005: 80: 1019-1025. (Pubitemid 41611922)
22. Taylor DO, Yowell RL, Kfoury AG, et al., Allograft coronary artery disease: Clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection. J Heart Lung Transplant 2000: 19: 518-521. (Pubitemid 30387056)
23. Vlad G, Ho EK, Vasilescu ER, et al., Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival. Hum Immunol 2009: 70: 589-594.
24. Liu Z, Colovai AI, Tugulea S, et al., Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest 1996: 98: 1150-1157. (Pubitemid 26299928)
25. Ciubotariu R, Liu Z, Colovai AI, et al., Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest 1998: 10: 398-405. (Pubitemid 28067337)
26. Baldwin WM III, Kasper EK, Zachary AA, et al., Beyond C4d: Other complement-related diagnostic approaches to antibody-mediated rejection. Am J Transplant 2004: 4: 311-318. (Pubitemid 38282285)
27. Platt JL, Nath KA,. Heme oxygenase: Protective gene or Trojan horse. Nat Med 1998: 4: 1364-1365. (Pubitemid 28553454)
28. Lynch RJ, Platt JL,. Accommodation in organ transplantation. Curr Opin Organ Transplant 2008: 13: 165-170. (Pubitemid 351374255)
29. Lynch RJ, Platt JL,. Accommodation in renal transplantation: Unanswered questions. Curr Opin Organ Transplant 2010: 15: 481-485.
30. Zhang X, Reed EF,. Effect of antibodies on endothelium. Am J Transplant 2009: 9: 2459-2465.
31. Li F, Atz ME, Reed EF,. Human leukocyte antigen antibodies in chronic transplant vasculopathy-mechanisms and pathways. Curr Opin Immunol 2009: 21: 557-562.